Harold E. Selick, Chief Executive Officer at THRESHOLD PHARMACEUTICALS INC (THLD), bought 300 shares at $0.56 ($168) on 2007-11-21, disclosed to the SEC on 2007-11-26.
Open-market purchase of $168 THLD by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| PDLI | BUY | 2014-11-28 | $48K | — | Filing → |
| THLD | BUY | 2011-03-15 | $100K | — | Filing → |
| THLD | BUY | 2009-10-06 | $97K | — | Filing → |